Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

accord healthcare b.v. - bupivacaine hydrochloride 5,275 mg/ml - eq. bupivacaine hydrochloride anhydrous 5 mg/ml - solution for injection - 5 mg/ml - bupivacaine hydrochloride 5.275 mg/ml - bupivacaine

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

accord healthcare b.v. - bupivacaine hydrochloride 5,275 mg/ml - eq. bupivacaine hydrochloride anhydrous 5 mg/ml - solution for injection - 5 mg/ml - bupivacaine hydrochloride 5.275 mg/ml - bupivacaine

Kenya - English - Pharmacy and Poisons Board

asence pharma private limited sarabhai campus dr. vikram sarabhai marg wadi - bupivacaine hydrochloride 5mg dextrose… - injection - bupivacaine hydrochloride 5mg dextrose… - local anesthetics: amides

United States - English - NLM (National Library of Medicine)

general injectables & vaccines, inc - bupivacaine hydrochloride (unii: 7tqo7w3vt8) (bupivacaine - unii:y8335394ro) - bupivacaine hydrochloride is indicated for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. only the 0.25% and 0.5% concentrations are indicated for obstetrical anesthesia. (see warnings .) experience with nonobstetrical surgical procedures in pregnant patients is not sufficient to recommend use of 0.75% concentration of bupivacaine hydrochloride in these patients. bupivacaine hydrochloride is not recommended for intravenous regional anesthesia (bier block). (see warnings .) the routes of administration and indicated bupivacaine hydrochloride concentrations are: (see dosage and administration for additional information.) standard textbooks should be consulted to determine the accepted procedures and techniques for the administration of bupivacaine hydrochloride. bupivacaine hydrochloride is contraindicated in obstetrical paracervical block anesthesia. its use in this technique h

United States - English - NLM (National Library of Medicine)

cardinal health 107, llc - bupivacaine hydrochloride (unii: 7tqo7w3vt8) (bupivacaine - unii:y8335394ro) - bupivacaine hydrochloride is indicated for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. only the 0.25% and 0.5% concentrations are indicated for obstetrical anesthesia (see warnings ). experience with nonobstetrical surgical procedures in pregnant patients is not sufficient to recommend use of 0.75% concentration of bupivacaine hydrochloride in these patients. bupivacaine hydrochloride is not recommended for intravenous regional anesthesia (bier block) (see warnings ). the routes of administration and indicated bupivacaine hydrochloride concentrations are: •local infiltration 0.25% •peripheral nerve block 0.25% and 0.5% •retrobulbar block 0.75% •sympathetic block 0.25% •lumbar epidural 0.25%, 0.5%, and 0.75% (0.75% not for obstetrical anesthesia) •caudal 0.25% and 0.5% •epidural test dose 0.5% with epinephrine 1:200,000 •dental blocks 0.5% with epinephrine 1:200,000 (see dosage and administration for additional information.) standard textbooks should be consulted to determine the accepted procedures and techniques for the administration of bupivacaine hydrochloride. bupivacaine hydrochloride is contraindicated in obstetrical paracervical block anesthesia. its use in this technique has resulted in fetal bradycardia and death. bupivacaine hydrochloride is contraindicated in patients with a known hypersensitivity to it or to any local anesthetic agent of the amide-type or to other components of bupivacaine hydrochloride solutions.

United States - English - NLM (National Library of Medicine)

medical purchasing solutions, llc - bupivacaine hydrochloride (unii: 7tqo7w3vt8) (bupivacaine - unii:y8335394ro) - bupivacaine hydrochloride is indicated for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. only the 0.25% and 0.5% concentrations are indicated for obstetrical anesthesia (see warnings ). experience with nonobstetrical surgical procedures in pregnant patients is not sufficient to recommend use of 0.75% concentration of bupivacaine hydrochloride in these patients. bupivacaine hydrochloride is not recommended for intravenous regional anesthesia (bier block) (see warnings ). the routes of administration and indicated bupivacaine hydrochloride concentrations are: •local infiltration 0.25% •peripheral nerve block 0.25% and 0.5% •retrobulbar block 0.75% •sympathetic block 0.25% •lumbar epidural 0.25%, 0.5%, and 0.75% (0.75% not for obstetrical anesthesia) •caudal 0.25% and 0.5% •epidural test dose 0.5% with epinephrine 1:200,000 •d

United States - English - NLM (National Library of Medicine)

brookfield pharmaceuticals, llc. - bupivacaine hydrochloride (unii: 7tqo7w3vt8) (bupivacaine - unii:y8335394ro) - bupivacaine hydrochloride in dextrose injection, usp is indicated for the production of subarachnoid block (spinal anesthesia). standard textbooks should be consulted to determine the accepted procedures and techniques for the administration of spinal anesthesia. bupivacaine hydrochloride in dextrose injection, usp is contraindicated in patients with a known hypersensitivity to it or to any local anesthetic agent of the amide-type. the following conditions preclude the use of spinal anesthesia: - severe hemorrhage, severe hypotension or shock and arrhythmias, such as complete heart block, which severely restrict cardiac output. - local infection at the site of proposed lumbar puncture. - septicemia.

United States - English - NLM (National Library of Medicine)

b. braun medical inc. - bupivacaine hydrochloride (unii: 7tqo7w3vt8) (bupivacaine - unii:y8335394ro) - bupivacaine hydrochloride in dextrose injection, usp is indicated for the production of subarachnoid block (spinal anesthesia). standard textbooks should be consulted to determine the accepted procedures and techniques for the administration of spinal anesthesia. bupivacaine hydrochloride in dextrose injection, usp is contraindicated in patients with a known hypersensitivity to it or to any local anesthetic agent of the amide-type. the following conditions preclude the use of spinal anesthesia: - severe hemorrhage, severe hypotension or shock and arrhythmias, such as complete heart block, which severely restrict cardiac output. - local infection at the site of proposed lumbar puncture. - septicemia.

United States - English - NLM (National Library of Medicine)

huons co., ltd. - bupivacaine hydrochloride (unii: 7tqo7w3vt8) (bupivacaine - unii:y8335394ro) - bupivacaine hydrochloride in dextrose injection, usp is indicated for subarachnoid injection in adults for the production of subarachnoid block (spinal anesthesia). bupivacaine hydrochloride in dextrose injection, usp is contraindicated in: - intravenous regional anesthesia (bier block) [ see warnings and precautions (5.8) ]. - patients with septicemia. - patients with severe hemorrhage, severe hypotension or shock, due to a reduced cardiac output. - patients with clinically significant arrhythmias, such as complete heartblock, due a reduced cardiac output. - patients with a known hypersensitivity to bupivacaine or to any local anesthetic agent of the amide-type or to other components of bupivacaine hydrochloride in dextrose injection, usp. - patients with local infection at the site of proposed lumbar puncture. risk summary the available data on the use of bupivacaine hydrochloride in dextrose injection, usp in pregnant women do not establish the presence or absence of developmental toxicity related

United States - English - NLM (National Library of Medicine)

henry schein, inc. - bupivacaine hydrochloride (unii: 7tqo7w3vt8) (bupivacaine - unii:y8335394ro), epinephrine bitartrate (unii: 30q7ki53ak) (epinephrine - unii:ykh834o4bh) - bupivacaine hydrochloride is indicated for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. only the 0.25% and 0.5% concentrations are indicated for obstetrical anesthesia. (see warnings .) experience with nonobstetrical surgical procedures in pregnant patients is not sufficient to recommend use of 0.75% concentration of bupivacaine hydrochloride in these patients. bupivacaine hydrochloride is not recommended for intravenous regional anesthesia (bier block). (see warnings .) the routes of administration and indicated bupivacaine hydrochloride concentrations are: (see dosage and administration for additional information.) standard textbooks should be consulted to determine the accepted procedures and techniques for the administration of bupivacaine hydrochloride. bupivacaine hydrochloride is contraindicated in obstetrical paracervical block anesthesia. its use in this technique ha